HIGHLIGHTS
SUMMARY
The current available treatment options for breast cancer patients include loco-regional (surgery or radiation) and systemic therapy (chemotherapy or endocrine therapy), depending on the tumor size, immunocytochemistry characteristics and cancer stage. The study aims to investigate the role of breast relaxometry as a possible imagingmarker in predicting the early response to therapy, after two cycles of neoadjuvant treatment, relying of the relaxometry characteristics of the tumors. The authors evaluated the role of breast relaxometry as a possible imagIn the current study, the authors evaluated the role of breast relaxometry as a possible imag . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.